These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38904783)

  • 1. Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?
    Sackner-Bernstein J
    J Neurol; 2024 Aug; 271(8):5687-5695. PubMed ID: 38904783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in Parkinson's disease.
    Vécsei L
    Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract]   [Full Text] [Related]  

  • 3. Safinamide for the treatment of Parkinson's disease.
    Kandadai RM; Jabeen SA; Kanikannan MA; Borgohain R
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):747-59. PubMed ID: 25300164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal Form of L-Dopa and SH-Sy5y Cell-Derived Exosomes Modulate the Tyrosine Hydroxylase/Dopamine Receptor D2 Signaling Pathway in Parkinson's Rat Models.
    Zarrin P; Dehghani Ashkezari M; Seifati SM
    J Mol Neurosci; 2021 Dec; 71(12):2583-2592. PubMed ID: 34125397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The concept of continuous dopaminergic stimulation in the treatment of late stages of Parkinson's disease].
    Titova NV; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):105-12. PubMed ID: 24596973
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of Continuous Dopaminergic Therapies in Parkinson's Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics.
    Demailly A; Moreau C; Devos D
    J Parkinsons Dis; 2024; 14(5):925-939. PubMed ID: 38848195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies in the treatment of early Parkinson's disease.
    Rinne UK
    Acta Neurol Scand Suppl; 1993; 146():50-3. PubMed ID: 8101417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications.
    Olanow CW; Obeso JA; Stocchi F
    Lancet Neurol; 2006 Aug; 5(8):677-87. PubMed ID: 16857573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic substitution in Parkinson's disease.
    Müller T
    Expert Opin Pharmacother; 2002 Oct; 3(10):1393-403. PubMed ID: 12387685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.
    Hurley MJ; Mash DC; Jenner P
    Eur J Neurosci; 2003 Nov; 18(9):2668-72. PubMed ID: 14622169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
    King JM; Muthian G; Mackey V; Smith M; Charlton C
    Life Sci; 2011 Oct; 89(17-18):638-43. PubMed ID: 21871902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease.
    Bell PT; Gilat M; O'Callaghan C; Copland DA; Frank MJ; Lewis SJ; Shine JM
    Hum Brain Mapp; 2015 Apr; 36(4):1278-91. PubMed ID: 25425542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of dopamine replacement therapy and its side effects in Parkinson's disease.
    You H; Mariani LL; Mangone G; Le Febvre de Nailly D; Charbonnier-Beaupel F; Corvol JC
    Cell Tissue Res; 2018 Jul; 373(1):111-135. PubMed ID: 29516217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dopamine agonists in early Parkinson's disease.
    Watts RL
    Neurology; 1997 Jul; 49(1 Suppl 1):S34-48. PubMed ID: 9222273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis and In Vitro Evaluation of Levodopa Stearic Acid Hydrazide Conjugate for the Management of Parkinson's DiseaseNovel Conjugate for Parkinson's Disease.
    Chinraj V; Reddy RA; Selvaraj J; Sureshkumar R
    Drug Res (Stuttg); 2024 Feb; 74(2):60-66. PubMed ID: 38286420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
    Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
    Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The initial treatment of Parkinson's disease should begin with levodopa.
    Weiner WJ
    Mov Disord; 1999 Sep; 14(5):716-24. PubMed ID: 10495031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of Deferiprone in Parkinson's Disease.
    Devos D; Labreuche J; Rascol O; Corvol JC; Duhamel A; Guyon Delannoy P; Poewe W; Compta Y; Pavese N; Růžička E; Dušek P; Post B; Bloem BR; Berg D; Maetzler W; Otto M; Habert MO; Lehericy S; Ferreira J; Dodel R; Tranchant C; Eusebio A; Thobois S; Marques AR; Meissner WG; Ory-Magne F; Walter U; de Bie RMA; Gago M; Vilas D; Kulisevsky J; Januario C; Coelho MVS; Behnke S; Worth P; Seppi K; Ouk T; Potey C; Leclercq C; Viard R; Kuchcinski G; Lopes R; Pruvo JP; Pigny P; Garçon G; Simonin O; Carpentier J; Rolland AS; Nyholm D; Scherfler C; Mangin JF; Chupin M; Bordet R; Dexter DT; Fradette C; Spino M; Tricta F; Ayton S; Bush AI; Devedjian JC; Duce JA; Cabantchik I; Defebvre L; Deplanque D; Moreau C;
    N Engl J Med; 2022 Dec; 387(22):2045-2055. PubMed ID: 36449420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.